The Biden administration on Oct. 21 issued a new proposed rule that would require health insurance providers to cover an ...
With Gilead sprinting to a likely approval next year for its long-acting pre-exposure | With GSK girding for competition from ...
Gilead Sciences’s decision to distribute HIV prevention drug lenacapavir made the news this month when they signed ...
Long-acting injectable PrEP is now to be covered without cost-sharing under Affordable Care Act rules, the Biden ...
The Biden-Harris administration has a historic opportunity to help end HIV. New, cutting-edge drugs that prevent HIV are ...
Gilead has grown to become a leader in the fight against HIV and has announced efforts to improve access to a new, highly ...
Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...
The new rule was contained within a larger proposal to ensure contraceptive coverage in the face of Republican attacks.
News Medical on MSN2d
Affordability and supply remain critical to the success of long-lasting HIV drugAffordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...
From oral PrEP, to injectables, rings, and implants, this year's HIV Research for Prevention conference was all about options ...
Winnie Byanyima, from UNAIDS: ‘Lenacapavir is more effective than condoms or PrEP in prevention’
The executive director of the organization says gender inequality is one of the most important drivers of new infections, ...
As groundbreaking studies continue to reshape the human immunodeficiency virus (HIV) landscape, emerging therapies and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback